Surgical treatment and ethanol injections in hyperplastic prostate in dogs

• Autorzy: Juodziukyniene N , Vaitkus V. , Aniuliene A.
• Języki publikacji: EN

Abstrakty

EN

The aim of the study was to evaluate the effect of two different methods of partial prostatectomy, to evaluate the influence of 96° ethanol injection on hyperplastic prostate and to compare the efficacy of ethanol injection with the efficacy of surgical treatment of the prostate. The study was performed in the years 20012003 in the surgical department of Dr. L. Kriauèeliûnas Small Animal Clinic. The surgical treatment (prostatectomy) was performed on 8 dogs using 2 methods: fillet and subcapsular. We compared the effectiveness and postoperative hystological evaluation of bioptats one and two weeks after surgery. We have performed ethanol injection on 5 dogs and evaluated the histological feature of prostatic tissues after injection to measure the effect of ethanol. The fillet method is technically simpler, shorter and the tissues of the prostate heal more quickly. Ethanol injection induces multi-focular coagulative necrosis, followed by fibrosis and atrophy of the prostate. This way of treatment is simpler and easier because there are no sections through prostate tissues. To avoid a section of the abdominal wall, a transurethral catheter can be used for the ethanol injection.

Słowa kluczowe

EN

dog; prostate; hyperplastic prostate; surgical treatment; ethanol injection; prostate tissue

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2007
• Tom: 63
• Numer: 03
• Opis fizyczny: p.301-304,fig.,ref.

Twórcy

autor

Juodziukyniene N

• Lithuania Veterinary Academy, Tilzes 18, LT-47181, Kaunas, Lithuania

autor

Vaitkus V.

autor

Aniuliene A.

Bibliografia

• 1.Benjamin D. S., Oberg K. C., Saukel G. W., Ruckle H. C., Stewart S. C.: Histopathologic evaluation of the canine prostate following electrovaporization. J. Urol. 1997, 157, 1144-1148. 2.Berry S. J., Strandberg J. D., Saunders W. J., Coffey D. S.: Development of canine benign prostatic hyperplasia with age. Prostate. 1986a, 9, 363-373.
• 3.Bojrab M. J., Crane S. W., Arnoczky S. P.: Current Techniques in Small Animal Surgery. Lea&Febiger, Philadelphia 1983, p. 360-369.
• 4.Chang W. Y., Sugimoto Y., Shidaifat F., Kulp S. K., Canatan H., Lin Y. C.: Gossypol induces spermidine/spermine N1-acetyltransferase in canine prostate epithelial cells. Biochem. Biophys. Res. Commun. 1997, 231, 383-388.
• 5.Darson M. F., Barrett D. M.: Transurethral enzyme injection future management of benign prostatic hyperplasia. Mayo Clin. Proc. 1998, 73, 908-911.
• 6.Foster R. S., Bihrle R., Sanghvi N. T., Fry F. J., Donohue J. P.: High-intensity focused ultrasound in the treatment of prostatic disease. Eur. Urol. 1993, 23, 29-33.
• 7.Fukunari N.: PEI therapy for thyroid lesions. Biomed. Pharmacother. 2002, 56, 79-82.
• 8.Galanty M., Bielecki W.: Changes in the prostate after the cryoapplication in dogs. Arch. Vet. Pathol. 1994, 34, 45-54.
• 9.Gelet A., Chapelon J. Y., Margonari J., Theillere Y., Gorry F., Cathignol D., Blanc E.: High-intensity focused ultrasound experimentation on human benign prostatic hypertrophy. Eur. Urol. 1993, 23, 44-47.
• 10.Goya N., Ishikawa N., Ito F., Ryoji O., Tokumoto T., Toma H., Yamagushi Y.: Ethanol injection therapy of the prostate for benign prostate hyperplasia: preliminary report on application of a new technique. Urology 1999, 162, 383-386.
• 11.Harmon W. J., Barrett D. M., Qian J., Lauvetz R. W., Bostwick D. G., Gocken M.: Transurethral enzymatic ablation of the prostate: canine model. Urology 1996, 48, 229-233.
• 12.Juniewics P. E., Barbolt T. A., Egy M. A., Frenette G., Dube J. Y., Tremblay R. R.: Effects of androgen and antiandrogen treatment on canine prostatic arginine esterase. Prostate 1990, 17, 101-111.
• 13.Kessler A., Blank A., Merhav H., Orron D., Konikoff F., Oren R., Figer A., Marouani N., Weiss J., Gutman M., Graif M.: Minimally invasive techniques in the treatment of liver tumors. Isr. Med. Assoc. J. 2002, 4, 1106-1110.
• 14.Kim E. D.: Ethanol injection for the treatment of benign prostatic hyperplasia. Curr. Urol. Rep. 2002, 3, 276-279.
• 15.Krawiec D. R., Heflin D.: Study of prostatic disease in dogs: 177 cases (1981- -1986). JAVMA 1992, 200, 1119-1122.
• 16.Laroque P. A., Prahalada S., Molon-Noblot S., Cohen S. M., Soper K., Duprat P., Peter C. P., van Zwieten M. J.: Quantitative evaluation of glandular and stromal compartments in hyperplastic dog prostates: effect of 5-alpha reductase inhibitors. Prostate 1995, 27, 121-128.
• 17.Leveillee R. J., Hoey M. F.: Enhanced radiofrequency ablation of canine prostate utilizing a liquid conductor: the virtual electrode. J. Endourol. 1996, 10, 5-11.
• 18.Littrup P. J., Lee F, Borlaza G. S., Sacknoff E. J., Torp-Pedersen S., Gray J. M.: Percutaneuos ablation of canine prostate using transrectal ultrasound guidance. Absolute ethanol and Nd:YAG laser. Invest Radiol. 1988, 23, 734-739.
• 19.Martov A. G., Pavlov D. A., Kirpatovskii V. I., Kudriavtsev Iu. V.: Intraprostatic injection of 96% ethanol in experimental animal model. Urologiia 2004, 6, 21-26.
• 20.Masala S., Fanucci E., Ronconi P., Sodani G., Taormina P., Romagnoli A., Simonetti G.: Treatment of intermetatarsal neuromas with alcohol injection under US guide. Radiol. Med. 2001, 102, 370-373.
• 21.Michel M. S., Kohrmann K. U., Weber A., Krautschick A. W., Alken P.: Rotoresect: New technique for resection of the prostate: Experimental phase. J. Endourol. 1996, 10, 473-478. 22.Morales A., Nickel J. C., Manley P. N.: Induction of controlled prostatic tissue necrosis by bacille Calmette-Guerin derivatives. Urol. Res. 1991, 19, 35-38.
• 23.Selman S. H., Keck R. W.: The effect of transurethral light on the canine prostate after sensitization with the photosensitizer TIN (II) etiopurpurin dichloride: A pilot study. J. Urol. 1994, 152, 2129-2132.
• 24.Suzuki T., Kurokawa K., Suzuki K., Imai K., Yamanaka H.: Thermal damage to normal and hyperplastic prostates due to transurethral balloon laser therapy in dogs. Int. J. Urol. 1994, 2, 162-166.
• 25.Vaitkus V., Samochvalov S.: Subtotal resection of canine prostatic gland (comparison of the two most frequently used methods). Veterinarija ir zootechnika 2002, 39, 61-63.
• 26.Zemskov V. S., Susak Ia. M., Koval’s’ka I. O., Deneka Ie. R., Kravchenko O. V., Kriuchyna Ie. A.: Ethanol injections in the integrated treatment of non-resectable malignant pancreatic tumor complicated by jaundice. Klin. Khir. 2002, 9, 25-27.
• 27.Zvara P., Karpman E., Stoppacher R., Esenler A. C., Plante M. K.: Ablation of canine prostate using transurethral intraprostatic absolute ethanol injection. Urology 1999, 54, 411-415.